Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Brain-derived tau {90000362}

Record Keys

Parent:[  ]
Brain-derived tau
Queue:[  ]


Initialisation date:[  ]
[  ]
[  ]

Meta Information

Structural Type:[  ]
Functional Type:[  ]
Function:[  ]


[  ]

Shared Reference Notes

  • [1.1
    - Brain-derived tau is a new blood-based biomarker that outperforms plasma total-tau and, unlike neurofilament light, shows specificity to #Alzheimer’s disease-type neurodegeneration.
  • [1.2] [#Alzheimer’s disease] [#Short Chain Fatty Acid] [#ApoE4 allele
    - #Amyloid-beta is a necessary factor in AD pathogenesis, its accumulation in and of itself is insufficient for neurodegeneration and cognitive decline. - pathological tau accumulation is closely linked with neurodegeneration and cognitive decline in AD and primary tauopathies. - apolipoprotein E (ApoE) isoforms, which strongly influence AD risk and regulate tau-mediated neurodegeneration, differentially affect the gut microbiota. - microbially produced short-chain fatty acids (SCFAs) are mediators of the neuroinflammation-neurodegeneration axis. - Supplementation of SCFAs to GF TE4 mice resulted in more reactive glial morphologies and gene expression as well as increased p-tau pathology.
  • [1.3] [#Alzheimer’s disease] [#Amyloid-beta
    - adding #Cinnamon or cinnamaldehyde to a cell medium can reduce tau aggregation, Amyloid β and increase cell viability. - #Cinnamon might be useful for preventing and reducing cognitive function impairment.

References Notes

[  ]